157 related articles for article (PubMed ID: 19700375)
1. Purification process development for HER1 extracellular domain as a potential therapeutic vaccine.
León D; Prieto Y; Fernández EG; Pérez N; Montero JA; Palacios J; Bulté D; de la Luz KR; Peña V; Ferro W; Sánchez B; Valdés R; Castillo A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3105-10. PubMed ID: 19700375
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the impact of manufacturing changes on the physicochemical properties and biological activity of Her1-ECD vaccine during product development.
Garcia Duardo K; Prieto Curbelo Y; Raymond Pous J; Rabasa Legón EY; Ramírez BS; Hernández KR; Castillo Vitoch A
Vaccine; 2015 Aug; 33(35):4292-9. PubMed ID: 26003492
[TBL] [Abstract][Full Text] [Related]
3. Accelerated purification process development of monoclonal antibodies for shortening time to clinic. Design and case study of chromatography processes.
Ishihara T; Kadoya T
J Chromatogr A; 2007 Dec; 1176(1-2):149-56. PubMed ID: 18035359
[TBL] [Abstract][Full Text] [Related]
4. Purification and assay of kinase-active EGF receptor from mammalian cells by immunoaffinity chromatography.
Wiepz GJ; Guadaramma AG; Fulgham DL; Bertics PJ
Methods Mol Biol; 2006; 327():25-38. PubMed ID: 16780210
[TBL] [Abstract][Full Text] [Related]
5. Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study.
Barro AM; Rivero AI; Goñi AL; Navarro BO; Angarica MM; Ramírez BS; Bedoya DM; Triana CG; Rodríguez AM; Parada ÁC
Vaccine; 2012 Dec; 31(1):89-95. PubMed ID: 23142132
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CNBr, FMP and hydrazide resins for immunoaffinity purification of factor IX.
Highsmith F; Regan T; Clark D; Drohan W; Tharakan J
Biotechniques; 1992 Mar; 12(3):418-23. PubMed ID: 1571154
[TBL] [Abstract][Full Text] [Related]
8. Purification of a human immunoglobulin G1 monoclonal antibody from transgenic tobacco using membrane chromatographic processes.
Yu D; McLean MD; Hall JC; Ghosh R
J Chromatogr A; 2008 Apr; 1187(1-2):128-37. PubMed ID: 18313066
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immobilized metal membrane affinity chromatography for purification of an immunoglobulin G1 monoclonal antibody.
Serpa G; Augusto EF; Tamashiro WM; Ribeiro MB; Miranda EA; Bueno SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):259-68. PubMed ID: 15664358
[TBL] [Abstract][Full Text] [Related]
10. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
11. A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha.
Huang Y; Bi J; Zhang Y; Zhou W; Li Y; Zhao L; Su Z
Protein Expr Purif; 2007 Dec; 56(2):301-10. PubMed ID: 17910922
[TBL] [Abstract][Full Text] [Related]
12. Immunoaffinity purification of juvenile hormone-binding protein from Galleria mellonella hemolymph.
Wieczorek E; Parkitna JM; Szkudlarek J; Ozyhar A; Kochman M
Acta Biochim Pol; 1996; 43(4):603-10. PubMed ID: 9104496
[TBL] [Abstract][Full Text] [Related]
13. Development of a two-step chromatography procedure that allows the purification of a high-purity anti-histone H1 monoclonal immunoglobulin M antibody with immunosuppressant activity.
Shimada Y; Goto T; Kawamoto S; Kiso T; Katayama A; Yamanaka Y; Aki T; Chiang KC; Nakano T; Goto S; Chen CL; Ohmori N; Ono K; Sato S
Biomed Chromatogr; 2008 Jan; 22(1):13-9. PubMed ID: 17604361
[TBL] [Abstract][Full Text] [Related]
14. Purification of the EGF receptor for oligosaccharide studies.
Gregoriou M
Methods Mol Biol; 1993; 14():189-98. PubMed ID: 8348235
[No Abstract] [Full Text] [Related]
15. Immunoaffinity purification of human haptoglobin using monoclonal antibodies.
Katnik I; Jadach J
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):303-8. PubMed ID: 8010870
[TBL] [Abstract][Full Text] [Related]
16. Perfusion immunoaffinity chromatography and its application in analysis and purification of biomolecules.
Zou H; Zhang Y; Lu P; Krull IS
Biomed Chromatogr; 1996; 10(3):122-6. PubMed ID: 8792862
[TBL] [Abstract][Full Text] [Related]
17. Membrane adsorbers as purification tools for monoclonal antibody purification.
Boi C
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):19-27. PubMed ID: 16996324
[TBL] [Abstract][Full Text] [Related]
18. Capture of human monoclonal antibodies from cell culture supernatant by ion exchange media exhibiting high charge density.
Necina R; Amatschek K; Jungbauer A
Biotechnol Bioeng; 1998 Dec; 60(6):689-98. PubMed ID: 10099479
[TBL] [Abstract][Full Text] [Related]
19. Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line.
Kumar A; Bansal V; Andersson J; Roychoudhury PK; Mattiasson B
J Chromatogr A; 2006 Jan; 1103(1):35-42. PubMed ID: 16368104
[TBL] [Abstract][Full Text] [Related]
20. Purification of human plasma fibronectin using immobilized gelatin and Arg affinity chromatography.
Speziale P; Visai L; Rindi S; Di Poto A
Nat Protoc; 2008; 3(3):525-33. PubMed ID: 18323821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
